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Introduction
Predicting the toxicity of mixtures is an important
current problem, and I'll talk about my personal view
ofthe matter. I think that there are two broad classes
of mixtures, one of which is the disposal mixtures:
thingsthat gointodumpsites. These arehighlyvariable
from one site to another, since they depend on specific
industrial operations, and it's difficult to extrapolate
from site to site. The other class is the complex mixture
from defined processes, such as combustion processes:
automobile emissions, emissions from powerplants, cig-
arette smoke, and so on.
I thinkthe current approach topredictingthetoxicity
ofcomplex mixtures is thoroughlyempirical, and I don't
know of any ways of doing things other than the way
they're actually beingdone. Namely, with disposal mix-
tures, such as those occurring in dump sites, one sum-
mates the risk from individual agents for which one has
existing data and ignores the possibility ofinteractions.
It is recognized that this approach may be inadequate,
but the problem of doing bioassays on individual dump
sites is so expensive as to be daunting.
The situation which, in many respects, is easieris the
case where the complex mixtures arise from defined
processes of major economic importance, for example,
the exhaust particulates from diesel engines. Here, it
is economically feasible to mount large bioassay pro-
grams. I suspect that probably 20 million dollars has
been spent on bioassays for diesel engine exhaust par-
ticulates by governmental and private sources. With
mixtures like this, the approach is to identify the dom-
inant effects, for example, with diesel particulates, can-
cer; cigarette smoke, the same; TCDD, the same, or
reproductive effects.
The potency is quantitated for the mixtures using
standard bioassays. Bioassays are also done to estimate
the variability in the potency. For example, with diesel
engines the carcinogenic potency can vary by a factor
of 10, depending on the type of diesel engine that is
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used. Thenthegravestandmostsensitive effectisiden-
tified; that is, the effect which is thought to occur at the
lowest level (for regulatory action). For example,
TCDD is not only potent for carcinogenic effects, but
also potent for reproductive effects. However, the
acceptance of a low-dose linear nonthreshold response
pattern forcarcinogenshasemphasizedthecarcinogenic
effect ofTCDD rather than the reproductive response.
So this is one person's view of how one goes about
predicting the toxicity of complex mixtures, namely,
that there are two approaches: the first is where one
identifies the risk from the individual components for
which there is data and accumulates the risk. And the
other is where the mixture is treated as a single agent
and potency variations in composition are taken into
consideration (1,2).
And that ends my opening remarks. Anybody have
comments or views to the contrary?
Discussion
DR. ERROL ZEIGER, NIEHS: I have one question
with regard to the first approach, which is to identify
the original components andthenessentially sumacross
the risk. Has any work been done by summing across
the individual risks of a mixture and coming up with
the correct value?
DR. ALBERT: This really hasn't been looked into too
much. Todd Thorslund at ClementAssociates estimated
the potency ofabout a dozen polycyclic aromatic hydro-
carbons (PAHs) relative to benzo[a]pyrene from exper-
iments in the literature where these agents were tested
individually. He then estimated the potency of a PAH
combination used by Schmahl in an experiment and
found that there was a close correspondence between
the estimated and observed potency ofthe combination
of PAHs.
However, this still leaves open the issue ofa complex
mixture, such as cigarette smoke tarwhere the number
of constituents can be well over 100,000, and where a
large number of the constituents were unidentified.
Here the question is whether the combined potency of186 R. E. ALBERT
a relatively few PAHs will simulate the potency of a
highly complex mixture.
DR. BERNARD SCHWETZ, NIEHS: You're right that
there's very little information on reconstructing the to-
tal toxicity ofcomplex mixtures, and there's very little
usingcarcinogenicity as anendpointbecause ofthecost.
Butifyou lookatthe studies thathavebeendonetaking
the most toxic components of complex mixtures and
adding them for various end points of toxicity or the
studies that have been done on simpler mixtures (e.g.,
binary, tertiary) and asking the question of whether
additivity describes the toxic effects seen with the com-
binations, most often it's less than additive. And when
surprises are seen where it's something beyond addi-
tive, it's seldom more than doubling in its effect.
So that the likelihood ofseeing surprises in the form
of synergistic interactions, where the data are totally
unpredictive, is quite rare. Even when they are seen,
they're fairly predictable by mechanism of action, for
instance, the cholinesterase inhibitors.
DR. RAYMOND YANG, NIEHS: I have one comment
and also I have something I'd like to sort of say in
response to Errol Zeiger's question. The comment is I
really admire your courage in takingthis topic, because
it seems to me from the literature that it's hard enough
to predict with twoas acombination whenyoudealwith
temporal relationships or with dose-response relation-
ships, let alone complex mixtures.
With respect to Errol Zeiger's question, there are
some studies in the literature. Infact, wayback, maybe
in the late sixties, Carol Weill and Henry Smith at the
Mellon Institute did 27 industrial chemicals with two as
the combination. They used what they called the har-
monic formula ofusing 1/LD50A + 1/LD502B to predict
the toxicity. The paper was published in TAP [Toxicol.
Appl. Pharmacol.]. There was also a Canadian group in
the seventies that tested certain pairs of compounds
which seemed to have synergistic effects.
We are initiating a program, the first stage ofwhich
is a study of 25 chemical mixtures in drinking water.
The study is in contract negotiation. The second phase
will be the selection of about eight chemicals that are
most frequently seen in hazardous waste sites and
groundwatercontamination. We are lookingforsystem-
atic experiments, with single chemicals, two as agroup,
three as a group, and so on. The test will most likely
be a 14-day type of study with more end points than
what's available in the literature.
These studies are in the planning stage. Hopefully in
the future we can answer the questions discussed here
a little better. Thank you.
DR. MARSHALL ANDERSON, NIEHS: Does it really
surprise you that ifyou mix together a series ofPAHs
thatthey're additive because they're probably allwork-
ing by the same mechanism? If I remember correctly,
there is data indicating that mutations induced by the
various polycyclics are proportional to the number of
adducts. What I'm saying is that for the compounds of
similar type you would expect they would be additive.
Now, suppose you had a mixture ofthings that acted
differently. That would be your best bet for getting
synergism. In the mouse skin, suppose you applied a
mixture of something like TPA and of DMBA, each at
low doses that wouldn't give tumors, then you would
see tumor formation with the mixture. That's the kind
ofexperiment that needs to be done to answerthe ques-
tion about mixtures instead of putting together things
that you know are going to act the same way.
DR. ALBERT: Well, there's no question but there are
concerns about interactions. The concern here is with
the practical world. Ideally you do studies to charac-
terize the behavior ofthe mixture as a whole. But more
often than not, you're in no position to do so. You have
to do the best bypulling out afew agents inthe mixture
and basing your overall estimate on what they add up
to. It's not a very satisfactory situation.
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